Page last updated: 2024-10-18

dalteparin and Group A Strep Infection

dalteparin has been researched along with Group A Strep Infection in 3 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"A diagnosis of cavernous sinus thrombosis was made based on clinical findings and confirmed by imaging in both patients."1.33Septic thrombosis of the cavernous sinus: two different mechanisms. ( Looi, A; Pavlovich, P; Rootman, J, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gomila-Sard, B1
Téllez-Castillo, CJ1
Sabater-Vidal, S1
Moreno-Muñoz, R1
Oliveira, GN1
Basso, S1
Sevivas, T1
Neves, N1
Pavlovich, P1
Looi, A1
Rootman, J1

Other Studies

3 other studies available for dalteparin and Group A Strep Infection

ArticleYear
[Early prosthetic joint infection due to Streptococcus oralis].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:9

    Topics: Aged; Antibiotic Prophylaxis; Anticoagulants; Arthritis, Infectious; Arthroplasty, Replacement, Knee

2009
Varicella complicated by cellulitis and deep vein thrombosis.
    BMJ case reports, 2017, Sep-07, Volume: 2017

    Topics: Anti-Bacterial Agents; Anticoagulants; Cellulitis; Chickenpox; Diagnosis, Differential; Enoxaparin;

2017
Septic thrombosis of the cavernous sinus: two different mechanisms.
    Orbit (Amsterdam, Netherlands), 2006, Volume: 25, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Cavernous Sinus Thrombosis; Drug Therapy, Combination;

2006